Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A Phase III open-label, single-arm, multi-center study to assess the safety and efficacy of brigimadlin (BI907828) treatment in patients with treatment-na??ve or pre-treated advanced dedifferentiated liposarcoma
Skubitz, K. (PI)
BOEHRINGER INGELHEIM VETMEDICA, INC.
11/15/23 → 10/30/33
Project: Research project
-
An International, Phase 3, Randomized, Multicenter, Open-label Study of Ripretinib vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumor (GIST) with KIT Exon 11 and Co-occurring KIT Exons 17 and/or 18 Mutations Who Were Previously Treated
Skubitz, K. (PI)
DECIPHERA PHARMACEUTICALS, LLC
4/20/23 → 4/30/28
Project: Research project
-
Long-term Safety Follow-up of Subjects With Giant Cell T
Skubitz, K. (PI)
11/1/17 → 12/31/24
Project: Research project
-
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma
Heater, N. K., Okuno, S., Robinson, S., Attia, S., Seetharam, M., Siontis, B. L., Yoon, J., Chawla, S., Milhem, M. M., Monga, V., Skubitz, K., Charlson, J., Hirbe, A. C., Weiss, M. C., Van Tine, B. & Agulnik, M., Apr 2023, In: Journal of Clinical Medicine. 12, 7, 2561.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
A Novel Tongue-Based Tumor With an RREB1-MRTFB Fusion: Variant Rhabdomyosarcoma or Aggressive Variant of Ectomesenchymal Chondromyxoid Tumor
Sumransub, N., Racila, E., Murugan, P., O'brien, C., Marette, S., Lassig, A. & Skubitz, K. M., Dec 31 2022, In: Cureus.Research output: Contribution to journal › Article › peer-review
-
Biclonal Desmoid-Type Fibromatosis With Two Beta-Catenin Mutations: Evidence for the Recruitment of Normal Myofibroblasts
Skubitz, K. M., Murugan, P. & Corless, C. L., Aug 14 2022, In: Cureus.Research output: Contribution to journal › Article › peer-review
-
Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy
Miller, D., Livingston, J. A., Park, Y., Posey, K., Godbole, S., Skubitz, K., Robinson, S. I., Agulnik, M., Davis, L., Van Tine, B. A., Hirbe, A. C. & Parkes, A., Sep 2022, In: Cancer medicine. 11, 18, p. 3471-3478 8 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Prospective Trial of Monocyte Count as a Biomarker of Hand-Foot Syndrome Among Patients With Soft Tissue Sarcomas Treated With Pegylated Liposomal Doxorubicin and Ifosfamide
Skubitz, K. M., Lindgren, B. R., Domingo-Musibay, E. & Cheng, E. Y., Apr 26 2022, In: Cureus.Research output: Contribution to journal › Article › peer-review